News
Every week, Real Estate and Development Reporter Jim Weiker rounds up the biggest business news of the week in his Breaking Ground newsletter. Check out the May 1 edition below and follow this ...
RBC lowers Amgen price target to $320 but keeps Outperform rating based on steady outlook for MariTide. Goldman sees MariTide efficacy risk in Phase 3 trial due to dose escalation, possibly ...
(RTTNews) - Amgen Inc. (AMGN) announced that it swung to profit in its first quarter of 2025 from a loss last year, helped by higher revenues and an unrealized gain on its BeiGene, Ltd. equity ...
Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings tomorrow afternoon. Here’s what to expect. Amgen beat analysts’ revenue expectations by 2.6% last quarter, reporting revenues of ...
Amgen (AMGN - Free Report) will report first-quarter 2025 results on May 1, after market close. In the last reported quarter, the company beat earnings expectations by 5.57%. The Zacks Consensus ...
THOUSAND OAKS, Calif., April 28, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter 2025 financial results on Thursday, May 1, 2025, after the close of ...
Vertex Pharmaceuticals, Amgen and Jazz Pharmaceuticals are among companies that received a positive opinion from European regulators for drugs that are al ...
The applicant for Tepezza is Amgen Europe B.V. Thyroid eye disease (TED), also known as Graves’ eye disease, is a rare autoimmune disease that triggers inflammation of muscles, fat, and other tissues ...
Amgen and Columbus State Community College are adding an advanced manufacturing certificate program, and Amgen is repeating and extending the apprenticeship developed with the school. How Columbus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback